COVID-19 Outbreak-Global Nuclear Medicine & Radiopharmaceuticals Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
- MAI4153014
- 114 Pages
- January 2021
- BFSI
The Nuclear Medicine & Radiopharmaceuticals market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Nuclear Medicine & Radiopharmaceuticals industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Nuclear Medicine & Radiopharmaceuticals market can be split based on product types, major applications, and important countries as follows:
Key players in the global Nuclear Medicine & Radiopharmaceuticals market covered in Chapter 12:
Cardinal Health Inc.
Lantheus Medical Imaging
Best Medical International，Inc
Jubilant Life Sciences
Cardinal Health
Advanced Accelerator Applications
Bayer
GE Healthcare
Actinium Pharmaceuticals，Inc
Curium
In Chapter 4 and 14.1, on the basis of types, the Nuclear Medicine & Radiopharmaceuticals market from 2015 to 2025 is primarily split into:
SPECT Radiopharmaceuticals (Diagnostics)
PET Radiopharmaceuticals (Diagnostics)
Beta Emitters (Therapeutics)
Alpha Emitters (Therapeutics)
Brachytherapy Isotopes (Therapeutics)
In Chapter 5 and 14.2, on the basis of applications, the Nuclear Medicine & Radiopharmaceuticals market from 2015 to 2025 covers:
Oncology
Thyroid
Cardiology
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
1 Nuclear Medicine & Radiopharmaceuticals Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Nuclear Medicine & Radiopharmaceuticals
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Nuclear Medicine & Radiopharmaceuticals industry
1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary
2.1 Market Overview
2.1.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size, 2015 – 2020
2.1.2 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Type, 2015 – 2020
2.1.3 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Application, 2015 – 2020
2.1.4 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Nuclear Medicine & Radiopharmaceuticals Industry Development
3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of Nuclear Medicine & Radiopharmaceuticals Analysis
3.2 Major Players of Nuclear Medicine & Radiopharmaceuticals
3.3 Nuclear Medicine & Radiopharmaceuticals Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Nuclear Medicine & Radiopharmaceuticals
3.3.3 Labor Cost of Nuclear Medicine & Radiopharmaceuticals
3.4 Market Distributors of Nuclear Medicine & Radiopharmaceuticals
3.5 Major Downstream Buyers of Nuclear Medicine & Radiopharmaceuticals Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Nuclear Medicine & Radiopharmaceuticals Market, by Type
4.1 Global Nuclear Medicine & Radiopharmaceuticals Value and Market Share by Type (2015-2020)
4.2 Global Nuclear Medicine & Radiopharmaceuticals Production and Market Share by Type (2015-2020)
4.3 Global Nuclear Medicine & Radiopharmaceuticals Value and Growth Rate by Type (2015-2020)
4.3.1 Global Nuclear Medicine & Radiopharmaceuticals Value and Growth Rate of SPECT Radiopharmaceuticals (Diagnostics)
4.3.2 Global Nuclear Medicine & Radiopharmaceuticals Value and Growth Rate of PET Radiopharmaceuticals (Diagnostics)
4.3.3 Global Nuclear Medicine & Radiopharmaceuticals Value and Growth Rate of Beta Emitters (Therapeutics)
4.3.4 Global Nuclear Medicine & Radiopharmaceuticals Value and Growth Rate of Alpha Emitters (Therapeutics)
4.3.5 Global Nuclear Medicine & Radiopharmaceuticals Value and Growth Rate of Brachytherapy Isotopes (Therapeutics)
4.4 Global Nuclear Medicine & Radiopharmaceuticals Price Analysis by Type (2015-2020)
5 Nuclear Medicine & Radiopharmaceuticals Market, by Application
5.1 Downstream Market Overview
5.2 Global Nuclear Medicine & Radiopharmaceuticals Consumption and Market Share by Application (2015-2020)
5.3 Global Nuclear Medicine & Radiopharmaceuticals Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Nuclear Medicine & Radiopharmaceuticals Consumption and Growth Rate of Oncology (2015-2020)
5.3.2 Global Nuclear Medicine & Radiopharmaceuticals Consumption and Growth Rate of Thyroid (2015-2020)
5.3.3 Global Nuclear Medicine & Radiopharmaceuticals Consumption and Growth Rate of Cardiology (2015-2020)
5.3.4 Global Nuclear Medicine & Radiopharmaceuticals Consumption and Growth Rate of Others (2015-2020)
6 Global Nuclear Medicine & Radiopharmaceuticals Market Analysis by Regions
6.1 Global Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Market Share by Regions
6.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Regions (2015-2020)
6.1.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Regions (2015-2020)
6.2 North America Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.3 Europe Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.6 South America Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7 North America Nuclear Medicine & Radiopharmaceuticals Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Market Share by Countries
7.2.1 North America Nuclear Medicine & Radiopharmaceuticals Sales by Countries (2015-2020)
7.2.2 North America Nuclear Medicine & Radiopharmaceuticals Revenue by Countries (2015-2020)
7.3 United States Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.4 Canada Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.5 Mexico Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8 Europe Nuclear Medicine & Radiopharmaceuticals Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Market Share by Countries
8.2.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Countries (2015-2020)
8.2.2 Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Countries (2015-2020)
8.3 Germany Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8.4 UK Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8.5 France Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8.6 Italy Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8.7 Spain Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8.8 Russia Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Countries (2015-2020)
9.2.2 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Countries (2015-2020)
9.3 China Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.4 Japan Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.5 South Korea Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.6 India Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.8 Australia Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
10 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Analysis by Countries
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Countries (2015-2020)
10.3 Saudi Arabia Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
10.4 UAE Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
10.5 Egypt Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
10.6 Nigeria Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
10.7 South Africa Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
11 South America Nuclear Medicine & Radiopharmaceuticals Market Analysis by Countries
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Market Share by Countries
11.2.1 South America Nuclear Medicine & Radiopharmaceuticals Sales by Countries (2015-2020)
11.2.2 South America Nuclear Medicine & Radiopharmaceuticals Revenue by Countries (2015-2020)
11.3 Brazil Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
11.4 Argentina Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
11.5 Columbia Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
11.6 Chile Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
12 Competitive Landscape
12.1 Cardinal Health Inc.
12.1.1 Cardinal Health Inc. Basic Information
12.1.2 Nuclear Medicine & Radiopharmaceuticals Product Introduction
12.1.3 Cardinal Health Inc. Production, Value, Price, Gross Margin 2015-2020
12.2 Lantheus Medical Imaging
12.2.1 Lantheus Medical Imaging Basic Information
12.2.2 Nuclear Medicine & Radiopharmaceuticals Product Introduction
12.2.3 Lantheus Medical Imaging Production, Value, Price, Gross Margin 2015-2020
12.3 Best Medical International，Inc
12.3.1 Best Medical International，Inc Basic Information
12.3.2 Nuclear Medicine & Radiopharmaceuticals Product Introduction
12.3.3 Best Medical International，Inc Production, Value, Price, Gross Margin 2015-2020
12.4 Jubilant Life Sciences
12.4.1 Jubilant Life Sciences Basic Information
12.4.2 Nuclear Medicine & Radiopharmaceuticals Product Introduction
12.4.3 Jubilant Life Sciences Production, Value, Price, Gross Margin 2015-2020
12.5 Cardinal Health
12.5.1 Cardinal Health Basic Information
12.5.2 Nuclear Medicine & Radiopharmaceuticals Product Introduction
12.5.3 Cardinal Health Production, Value, Price, Gross Margin 2015-2020
12.6 Advanced Accelerator Applications
12.6.1 Advanced Accelerator Applications Basic Information
12.6.2 Nuclear Medicine & Radiopharmaceuticals Product Introduction
12.6.3 Advanced Accelerator Applications Production, Value, Price, Gross Margin 2015-2020
12.7 Bayer
12.7.1 Bayer Basic Information
12.7.2 Nuclear Medicine & Radiopharmaceuticals Product Introduction
12.7.3 Bayer Production, Value, Price, Gross Margin 2015-2020
12.8 GE Healthcare
12.8.1 GE Healthcare Basic Information
12.8.2 Nuclear Medicine & Radiopharmaceuticals Product Introduction
12.8.3 GE Healthcare Production, Value, Price, Gross Margin 2015-2020
12.9 Actinium Pharmaceuticals，Inc
12.9.1 Actinium Pharmaceuticals，Inc Basic Information
12.9.2 Nuclear Medicine & Radiopharmaceuticals Product Introduction
12.9.3 Actinium Pharmaceuticals，Inc Production, Value, Price, Gross Margin 2015-2020
12.10 Curium
12.10.1 Curium Basic Information
12.10.2 Nuclear Medicine & Radiopharmaceuticals Product Introduction
12.10.3 Curium Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Nuclear Medicine & Radiopharmaceuticals Market Forecast
14.1 Global Nuclear Medicine & Radiopharmaceuticals Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 SPECT Radiopharmaceuticals (Diagnostics) Market Value and Volume Forecast (2020-2025)
14.1.2 PET Radiopharmaceuticals (Diagnostics) Market Value and Volume Forecast (2020-2025)
14.1.3 Beta Emitters (Therapeutics) Market Value and Volume Forecast (2020-2025)
14.1.4 Alpha Emitters (Therapeutics) Market Value and Volume Forecast (2020-2025)
14.1.5 Brachytherapy Isotopes (Therapeutics) Market Value and Volume Forecast (2020-2025)
14.2 Global Nuclear Medicine & Radiopharmaceuticals Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Oncology Market Value and Volume Forecast (2020-2025)
14.2.2 Thyroid Market Value and Volume Forecast (2020-2025)
14.2.3 Cardiology Market Value and Volume Forecast (2020-2025)
14.2.4 Others Market Value and Volume Forecast (2020-2025)
14.3 Nuclear Medicine & Radiopharmaceuticals Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
List of Tables and Figures
Figure Product Picture of Nuclear Medicine & Radiopharmaceuticals
Table Product Specification of Nuclear Medicine & Radiopharmaceuticals
Table Nuclear Medicine & Radiopharmaceuticals Key Market Segments
Table Key Players Nuclear Medicine & Radiopharmaceuticals Covered
Figure Global Nuclear Medicine & Radiopharmaceuticals Market Size, 2015 – 2025
Table Different Types of Nuclear Medicine & Radiopharmaceuticals
Figure Global Nuclear Medicine & Radiopharmaceuticals Value ($) Segment by Type from 2015-2020
Figure Global Nuclear Medicine & Radiopharmaceuticals Market Share by Types in 2019
Table Different Applications of Nuclear Medicine & Radiopharmaceuticals
Figure Global Nuclear Medicine & Radiopharmaceuticals Value ($) Segment by Applications from 2015-2020
Figure Global Nuclear Medicine & Radiopharmaceuticals Market Share by Applications in 2019
Figure Global Nuclear Medicine & Radiopharmaceuticals Market Share by Regions in 2019
Figure North America Nuclear Medicine & Radiopharmaceuticals Production Value ($) and Growth Rate (2015-2020)
Figure Europe Nuclear Medicine & Radiopharmaceuticals Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Nuclear Medicine & Radiopharmaceuticals Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Production Value ($) and Growth Rate (2015-2020)
Figure South America Nuclear Medicine & Radiopharmaceuticals Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Nuclear Medicine & Radiopharmaceuticals
Table Upstream Raw Material Suppliers of Nuclear Medicine & Radiopharmaceuticals with Contact Information
Table Major Players Headquarters, and Service Area of Nuclear Medicine & Radiopharmaceuticals
Figure Major Players Production Value Market Share of Nuclear Medicine & Radiopharmaceuticals in 2019
Table Major Players Nuclear Medicine & Radiopharmaceuticals Product Types in 2019
Figure Production Process of Nuclear Medicine & Radiopharmaceuticals
Figure Manufacturing Cost Structure of Nuclear Medicine & Radiopharmaceuticals
Figure Channel Status of Nuclear Medicine & Radiopharmaceuticals
Table Major Distributors of Nuclear Medicine & Radiopharmaceuticals with Contact Information
Table Major Downstream Buyers of Nuclear Medicine & Radiopharmaceuticals with Contact Information
Table Global Nuclear Medicine & Radiopharmaceuticals Value ($) by Type (2015-2020)
Table Global Nuclear Medicine & Radiopharmaceuticals Value Share by Type (2015-2020)
Figure Global Nuclear Medicine & Radiopharmaceuticals Value Share by Type (2015-2020)
Table Global Nuclear Medicine & Radiopharmaceuticals Production by Type (2015-2020)
Table Global Nuclear Medicine & Radiopharmaceuticals Production Share by Type (2015-2020)
Figure Global Nuclear Medicine & Radiopharmaceuticals Production Share by Type (2015-2020)
Figure Global Nuclear Medicine & Radiopharmaceuticals Value ($) and Growth Rate of SPECT Radiopharmaceuticals (Diagnostics) (2015-2020)
Figure Global Nuclear Medicine & Radiopharmaceuticals Value ($) and Growth Rate of PET Radiopharmaceuticals (Diagnostics) (2015-2020)
Figure Global Nuclear Medicine & Radiopharmaceuticals Value ($) and Growth Rate of Beta Emitters (Therapeutics) (2015-2020)
Figure Global Nuclear Medicine & Radiopharmaceuticals Value ($) and Growth Rate of Alpha Emitters (Therapeutics) (2015-2020)
Figure Global Nuclear Medicine & Radiopharmaceuticals Value ($) and Growth Rate of Brachytherapy Isotopes (Therapeutics) (2015-2020)
Figure Global Nuclear Medicine & Radiopharmaceuticals Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Nuclear Medicine & Radiopharmaceuticals Consumption by Application (2015-2020)
Table Global Nuclear Medicine & Radiopharmaceuticals Consumption Market Share by Application (2015-2020)
Figure Global Nuclear Medicine & Radiopharmaceuticals Consumption Market Share by Application (2015-2020)
Figure Global Nuclear Medicine & Radiopharmaceuticals Consumption and Growth Rate of Oncology (2015-2020)
Figure Global Nuclear Medicine & Radiopharmaceuticals Consumption and Growth Rate of Thyroid (2015-2020)
Figure Global Nuclear Medicine & Radiopharmaceuticals Consumption and Growth Rate of Cardiology (2015-2020)
Figure Global Nuclear Medicine & Radiopharmaceuticals Consumption and Growth Rate of Others (2015-2020)
Figure Global Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Global Nuclear Medicine & Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020)
Table Global Nuclear Medicine & Radiopharmaceuticals Sales by Regions (2015-2020)
Table Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Regions (2015-2020)
Table Global Nuclear Medicine & Radiopharmaceuticals Revenue (M USD) by Regions (2015-2020)
Table Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Regions (2015-2020)
Table Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Regions in 2015
Table Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Regions in 2019
Figure North America Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Europe Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure South America Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Nuclear Medicine & Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020)
Table North America Nuclear Medicine & Radiopharmaceuticals Sales by Countries (2015-2020)
Table North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table North America Nuclear Medicine & Radiopharmaceuticals Revenue (M USD) by Countries (2015-2020)
Table North America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure United States Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Canada Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Mexico Nuclear Medicine & Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Nuclear Medicine & Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020)
Table Europe Nuclear Medicine & Radiopharmaceuticals Sales by Countries (2015-2020)
Table Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table Europe Nuclear Medicine & Radiopharmaceuticals Revenue (M USD) by Countries (2015-2020)
Table Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure Germany Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure UK Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure France Nuclear Medicine & Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Italy Nuclear Medicine & Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Spain Nuclear Medicine & Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Russia Nuclear Medicine & Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Countries (2015-2020)
Table Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure China Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Japan Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure South Korea Nuclear Medicine & Radiopharmaceuticals Sales and Growth (2015-2020)
Figure India Nuclear Medicine & Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Australia Nuclear Medicine & Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Middle East Nuclear Medicine & Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020)
Table Middle East Nuclear Medicine & Radiopharmaceuticals Sales by Countries (2015-2020)
Table Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure UAE Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Egypt Nuclear Medicine & Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Nigeria Nuclear Medicine & Radiopharmaceuticals Sales and Growth (2015-2020)
Figure South Africa Nuclear Medicine & Radiopharmaceuticals Sales and Growth (2015-2020)
Figure South America Nuclear Medicine & Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020)
Table South America Nuclear Medicine & Radiopharmaceuticals Sales by Countries (2015-2020)
Table South America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table South America Nuclear Medicine & Radiopharmaceuticals Revenue (M USD) by Countries (2015-2020)
Table South America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure Brazil Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Argentina Nuclear Medicine & Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Columbia Nuclear Medicine & Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Chile Nuclear Medicine & Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Top 3 Market Share of Nuclear Medicine & Radiopharmaceuticals Companies in 2019
Figure Top 6 Market Share of Nuclear Medicine & Radiopharmaceuticals Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Cardinal Health Inc. Profile
Table Cardinal Health Inc. Product Introduction
Figure Cardinal Health Inc. Production and Growth Rate
Figure Cardinal Health Inc. Value ($) Market Share 2015-2020
Table Lantheus Medical Imaging Profile
Table Lantheus Medical Imaging Product Introduction
Figure Lantheus Medical Imaging Production and Growth Rate
Figure Lantheus Medical Imaging Value ($) Market Share 2015-2020
Table Best Medical International，Inc Profile
Table Best Medical International，Inc Product Introduction
Figure Best Medical International，Inc Production and Growth Rate
Figure Best Medical International，Inc Value ($) Market Share 2015-2020
Table Jubilant Life Sciences Profile
Table Jubilant Life Sciences Product Introduction
Figure Jubilant Life Sciences Production and Growth Rate
Figure Jubilant Life Sciences Value ($) Market Share 2015-2020
Table Cardinal Health Profile
Table Cardinal Health Product Introduction
Figure Cardinal Health Production and Growth Rate
Figure Cardinal Health Value ($) Market Share 2015-2020
Table Advanced Accelerator Applications Profile
Table Advanced Accelerator Applications Product Introduction
Figure Advanced Accelerator Applications Production and Growth Rate
Figure Advanced Accelerator Applications Value ($) Market Share 2015-2020
Table Bayer Profile
Table Bayer Product Introduction
Figure Bayer Production and Growth Rate
Figure Bayer Value ($) Market Share 2015-2020
Table GE Healthcare Profile
Table GE Healthcare Product Introduction
Figure GE Healthcare Production and Growth Rate
Figure GE Healthcare Value ($) Market Share 2015-2020
Table Actinium Pharmaceuticals，Inc Profile
Table Actinium Pharmaceuticals，Inc Product Introduction
Figure Actinium Pharmaceuticals，Inc Production and Growth Rate
Figure Actinium Pharmaceuticals，Inc Value ($) Market Share 2015-2020
Table Curium Profile
Table Curium Product Introduction
Figure Curium Production and Growth Rate
Figure Curium Value ($) Market Share 2015-2020
Table Market Driving Factors of Nuclear Medicine & Radiopharmaceuticals
Table Merger, Acquisition and New Investment
Table Global Nuclear Medicine & Radiopharmaceuticals Market Value ($) Forecast, by Type
Table Global Nuclear Medicine & Radiopharmaceuticals Market Volume Forecast, by Type
Figure Global Nuclear Medicine & Radiopharmaceuticals Market Value ($) and Growth Rate Forecast of SPECT Radiopharmaceuticals (Diagnostics) (2020-2025)
Figure Global Nuclear Medicine & Radiopharmaceuticals Market Volume ($) and Growth Rate Forecast of SPECT Radiopharmaceuticals (Diagnostics) (2020-2025)
Figure Global Nuclear Medicine & Radiopharmaceuticals Market Value ($) and Growth Rate Forecast of PET Radiopharmaceuticals (Diagnostics) (2020-2025)
Figure Global Nuclear Medicine & Radiopharmaceuticals Market Volume ($) and Growth Rate Forecast of PET Radiopharmaceuticals (Diagnostics) (2020-2025)
Figure Global Nuclear Medicine & Radiopharmaceuticals Market Value ($) and Growth Rate Forecast of Beta Emitters (Therapeutics) (2020-2025)
Figure Global Nuclear Medicine & Radiopharmaceuticals Market Volume ($) and Growth Rate Forecast of Beta Emitters (Therapeutics) (2020-2025)
Figure Global Nuclear Medicine & Radiopharmaceuticals Market Value ($) and Growth Rate Forecast of Alpha Emitters (Therapeutics) (2020-2025)
Figure Global Nuclear Medicine & Radiopharmaceuticals Market Volume ($) and Growth Rate Forecast of Alpha Emitters (Therapeutics) (2020-2025)
Figure Global Nuclear Medicine & Radiopharmaceuticals Market Value ($) and Growth Rate Forecast of Brachytherapy Isotopes (Therapeutics) (2020-2025)
Figure Global Nuclear Medicine & Radiopharmaceuticals Market Volume ($) and Growth Rate Forecast of Brachytherapy Isotopes (Therapeutics) (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Oncology (2020-2025)
Figure Market Volume and Growth Rate Forecast of Oncology (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Thyroid (2020-2025)
Figure Market Volume and Growth Rate Forecast of Thyroid (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Cardiology (2020-2025)
Figure Market Volume and Growth Rate Forecast of Cardiology (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Others (2020-2025)
Figure Market Volume and Growth Rate Forecast of Others (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter’s Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
Similar Reports
Online banking or internet banking is a service provided by retail bank, virtual bank (neo banks) or credit unions. Online banking provides the customers with a secure website through which they can conduct financial transactions. Recent trends show that, customers are keenly adopting on...
- Publish Date: July 31, 2017
- $5370
ATMs have evolved from just cash dispensing machines to multifunctional equipment that provide not only cash withdrawal facilities but offer currency conversions facilities, account information, deposits, transfers, bill payment, cash recycling among other services. The Asia-Pacific region is becoming increasingly characterized by technology-facilitated transactions. ...
- Publish Date: March 1, 2016
- $3390
The Global P2P Industry 2016 Deep Market Research Report is a professional and in-depth study on the current state of the P2P industry. The report provides a basic overview of the industry including definitions and classifications. The P2P market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. ...
- Publish Date: January 15, 2016
- $2800
